Eric Wallen

10.1k total citations
179 papers, 5.6k citations indexed

About

Eric Wallen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Eric Wallen has authored 179 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Surgery, 71 papers in Pulmonary and Respiratory Medicine and 33 papers in Urology. Recurrent topics in Eric Wallen's work include Bladder and Urothelial Cancer Treatments (69 papers), Urinary and Genital Oncology Studies (41 papers) and Renal cell carcinoma treatment (35 papers). Eric Wallen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (69 papers), Urinary and Genital Oncology Studies (41 papers) and Renal cell carcinoma treatment (35 papers). Eric Wallen collaborates with scholars based in United States, Canada and United Kingdom. Eric Wallen's co-authors include Raj S. Pruthi, Matthew E. Nielsen, Angela B. Smith, Erik Kouba, Jeff Nix, W. Kimryn Rathmell, Michael Woods, Raj Kurpad, Allison M. Deal and Mathew Raynor and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Eric Wallen

169 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Wallen United States 43 2.8k 2.0k 1.3k 1.2k 922 179 5.6k
Simon P. Kim United States 43 2.5k 0.9× 3.3k 1.7× 859 0.6× 1.2k 1.0× 1.2k 1.3× 198 6.0k
Daniel A. Barocas United States 48 3.4k 1.2× 3.6k 1.8× 1.5k 1.1× 718 0.6× 1.4k 1.5× 210 7.2k
Raj S. Pruthi United States 51 5.2k 1.9× 2.2k 1.1× 2.3k 1.7× 1.4k 1.2× 1.5k 1.6× 229 8.4k
Matthew E. Nielsen United States 52 4.3k 1.6× 2.9k 1.5× 1.6k 1.2× 1.6k 1.3× 1.7k 1.9× 235 8.2k
Sam S. Chang United States 49 4.5k 1.6× 3.1k 1.5× 2.1k 1.5× 1.1k 0.9× 1.2k 1.3× 187 7.5k
Cheryl T. Lee United States 41 3.8k 1.4× 1.2k 0.6× 1.6k 1.2× 830 0.7× 1.2k 1.3× 124 5.0k
Claire L. Vale United Kingdom 25 2.2k 0.8× 1.3k 0.6× 645 0.5× 508 0.4× 996 1.1× 56 4.4k
Matthew K. Tollefson United States 37 2.6k 1.0× 1.7k 0.9× 882 0.7× 335 0.3× 1.0k 1.1× 198 4.7k
Daniel D. Sjoberg United States 39 2.1k 0.8× 3.8k 1.9× 765 0.6× 687 0.6× 978 1.1× 205 6.1k
David C. Miller United States 41 2.4k 0.9× 4.7k 2.4× 707 0.5× 2.2k 1.8× 1.3k 1.4× 181 6.8k

Countries citing papers authored by Eric Wallen

Since Specialization
Citations

This map shows the geographic impact of Eric Wallen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wallen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wallen more than expected).

Fields of papers citing papers by Eric Wallen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Wallen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wallen. The network helps show where Eric Wallen may publish in the future.

Co-authorship network of co-authors of Eric Wallen

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Wallen. A scholar is included among the top collaborators of Eric Wallen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Wallen. Eric Wallen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Li, Weili Lin, Michael Woods, et al.. (2024). Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma. UNC Libraries.
2.
Han, Misop, Stanley J. Hamstra, Sean Hogan, et al.. (2023). Trainee Physician Milestone Ratings and Patient Complaints in Early Posttraining Practice. JAMA Network Open. 6(4). e237588–e237588. 15 indexed citations
3.
Lehman, Erik, Gary E. Lemack, Marisa Clifton, et al.. (2023). Practice Readiness? Trends in Chief Resident Year Training Experience Across 13 Residency Programs. Urology Practice. 11(2). 430–438.
4.
McNaull, Peggy, Allison M. Deal, R. Matthew Coward, et al.. (2020). Implementation of Postoperative Standard Opioid Prescribing Schedules Reduces Opioid Prescriptions Without Change in Patient-reported Pain Outcomes. Urology. 148. 126–133. 6 indexed citations
5.
McMahon, Stephen J., Ramsankar Basak, Xi Zhou, et al.. (2020). Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment. Urology. 149. 103–109. 2 indexed citations
6.
Filippou, Pauline, Allison M. Deal, Eric Wallen, et al.. (2019). The Presence of Gender Bias in Letters of Recommendations Written for Urology Residency Applicants. Urology. 134. 56–61. 86 indexed citations
7.
Brooks, Samira A., Amir H. Khandani, Julia R. Fielding, et al.. (2016). Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression. Clinical Cancer Research. 22(12). 2950–2959. 19 indexed citations
8.
Greene, Peter S., Anne Meyer, Ke Meng, et al.. (2015). Understanding the Relationship Between 30- and 90-Day Emergency Room Visits, Readmissions, and Complications after Radical Cystectomy. Journal of the American College of Surgeons. 221(4). S135–S135.
9.
Brannon, A. Rose, Scott M. Haake, Kathryn E. Hacker, et al.. (2011). Meta-analysis of Clear Cell Renal Cell Carcinoma Gene Expression Defines a Variant Subgroup and Identifies Gender Influences on Tumor Biology. European Urology. 61(2). 258–268. 85 indexed citations
10.
Whang, Young E., Andrew J. Armstrong, W. Kimryn Rathmell, et al.. (2011). A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 31(1). 82–86. 69 indexed citations
11.
Smith, Angela B., Mathew Raynor, Christopher L. Amling, et al.. (2011). Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques. 22(1). 17–21. 79 indexed citations
12.
Sliwinski, Anthony J., Eric Wallen, John F. Ward, et al.. (2011). POD-07.08 Morbidity of High Intensity Focused Ultrasound (HIFU) as a Primary Monotherapy for Low-Risk Localized Prostate Cancer: Outcomes from the ENLIGHT Trial. Urology. 78(3). S25–S26. 1 indexed citations
13.
Pruthi, Raj S., Matthew E. Nielsen, Samuel A. Heathcote, et al.. (2010). A phase II trial of neoadjuvant erlotinib in patients with muscle‐invasive bladder cancer undergoing radical cystectomy: clinical and pathological results. British Journal of Urology. 106(3). 349–354. 84 indexed citations
14.
Pruthi, Raj S., et al.. (2010). Robotic-Assisted Laparoscopic Intracorporeal Urinary Diversion. European Urology. 57(6). 1013–1021. 102 indexed citations
15.
Rathmell, W. Kimryn, Raj S. Pruthi, & Eric Wallen. (2009). Neoadjuvant treatment of renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 28(1). 69–73. 7 indexed citations
16.
Pruthi, Raj S. & Eric Wallen. (2008). Robotic-Assisted Laparoscopic Pelvic Lymphadenectomy for Bladder Cancer: A Surgical Atlas. Journal of Laparoendoscopic & Advanced Surgical Techniques. 19(1). 71–74. 14 indexed citations
17.
Pruthi, Raj S., et al.. (2008). Robotic Anterior Pelvic Exenteration for Bladder Cancer in the Female: Outcomes and Comparisons to Their Male Counterparts. Journal of Laparoendoscopic & Advanced Surgical Techniques. 19(1). 23–27. 12 indexed citations
18.
19.
Pruthi, Raj S., et al.. (2007). Androgen-Independent Prostate Cancer Treated with Resection of the Solitary Metastatic Site. Urologia Internationalis. 79(4). 371–373. 24 indexed citations
20.
Pruthi, Raj S., Dominic T. Moore, Culley C. Carson, et al.. (2006). Phase II Trial of Celecoxib in Prostate-Specific Antigen Recurrent Prostate Cancer after Definitive Radiation Therapy or Radical Prostatectomy. Clinical Cancer Research. 12(7). 2172–2177. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon P. Kim Breakdown of academic impact, for papers by Daniel A. Barocas Breakdown of academic impact, for papers by Raj S. Pruthi Breakdown of academic impact, for papers by Matthew E. Nielsen Breakdown of academic impact, for papers by Sam S. Chang Breakdown of academic impact, for papers by Cheryl T. Lee Breakdown of academic impact, for papers by Claire L. Vale Breakdown of academic impact, for papers by Matthew K. Tollefson Breakdown of academic impact, for papers by Daniel D. Sjoberg Breakdown of academic impact, for papers by David C. Miller
Rankless by CCL
2026